サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566883

経腸シリンジ市場：タイプ別、年齢層別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Enteral Syringe Market By Type (Reusable, Disposable), By Age Group (Adults, Pediatrics) By End User (Hospitals, Ambulatory Surgical Centers, Homecare) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 251 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
経腸シリンジ市場：タイプ別、年齢層別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 251 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の経腸シリンジ市場は、2023年に3億8,360万米ドルと評価され、2024年から2033年にかけてCAGR 5.3％で成長し、2033年には6億4,360万米ドルに達すると予測されています。

経腸シリンジは、液体薬、栄養剤、または液体を消化管に直接投与するために使用される特殊な医療機器であり、通常は栄養チューブを通して使用されます。このシリンジは、正確な容量測定、経腸栄養チューブとの適合性、偶発的な接続解除や漏れを防止する安全機構などの特徴を備えて特別に設計されています。

経腸シリンジ市場の成長は、貧困、栄養価の高い食品への不十分なアクセス、慢性疾患、高齢化などが栄養失調の発生率上昇に寄与しています。経腸シリンジは、必要な栄養素を消化管に直接送り込むという重要な役割を果たし、経口摂取が不十分または不可能な場合に患者が十分な栄養を摂取できるようにします。さらに、在宅医療への動向の高まりが市場を牽引しています。病院に入院するよりも自宅で経腸投薬や栄養補給を求める患者の増加に伴い、使い勝手の良い経腸シリンジへの需要が高まっています。そのため、メーカーは使いやすく、在宅経腸栄養機器と互換性のあるシリンジを製造しています。

しかし、厳しい政府規制が市場成長の抑制要因となっています。規制当局は、安全性、有効性、品質を確保するため、経腸シリンジを含む医療機器に厳しい基準と承認プロセスを課しています。対照的に、副作用の少ない先進的な経腸栄養デバイスの市場開拓は、市場成長の機会となります。経腸シリンジの設計、材料、機能性における革新は、患者の快適性を高め、合併症を減らし、治療成績を向上させることを目的としています。例えば、Baxter International Inc.による、人間工学に基づいた設計、正確な投与量制御機構、逆流防止機能を備えた経腸シリンジの開発は、誤嚥やチューブに関連する合併症のリスクを最小限に抑え、経腸栄養をより安全で効率的なものにします。

セグメンテーションの概要

経腸シリンジ市場は、タイプ、年齢層、エンドユーザー、地域に区分されます。タイプによって、市場は再使用型と使い捨て型に二分されます。年齢層別では、成人と小児に分けられます。エンドユーザー別では、病院、外来手術センター（ASCS）、在宅医療に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されます。

競合シナリオ

本レポートはカスタマイズが可能です。

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要プレーヤーの詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 耳鼻咽喉科用シリンジ市場：タイプ別

  • 市場概要
  • 再利用可能
  • 使い捨て

第5章 耳鼻咽喉科用シリンジ市場：年齢層別

  • 市場概要
  • 成人
  • 小児科

第6章 耳鼻咽喉科用シリンジ市場：エンドユーザー別

  • 市場概要
  • 病院
  • 外来手術センター
  • 在宅医療

第7章 経腸シリンジ市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国の経腸シリンジ市場
    • カナダの腸用シリンジ市場
    • メキシコの経腸シリンジ市場
  • 欧州
    • 主要市場動向と機会
    • ドイツの腸用シリンジ市場
    • フランスの腸用シリンジ市場
    • 英国の腸用シリンジ市場
    • イタリアの腸用シリンジ市場
    • スペインの腸用シリンジ市場
    • その他欧州の腸用シリンジ市場
  • アジア太平洋
    • 主な市場動向と機会
    • 日本の腸用シリンジ市場
    • 中国の腸用シリンジ市場
    • インドの腸用シリンジ市場
    • オーストラリアの腸用シリンジ市場
    • 韓国の腸用シリンジ市場
    • その他アジア太平洋の腸用シリンジ市場
  • ラテンアメリカ・中東・アフリカ
    • 主な市場動向と機会
    • ブラジルの腸用シリンジ市場
    • サウジアラビアの腸用シリンジ市場
    • 南アフリカの腸用シリンジ市場
    • その他のラテンアメリカ・中東・アフリカの腸用シリンジ市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Fresenius SE And Co. KGaA
  • Boston Scientific Corporation
  • Danone
  • Cook Medical, Inc.
  • Cardinal Health Inc.
  • Becton, Dickinson And Company
  • Moog Inc.
  • B. Braun Melsungen AG
  • Owens And Minor, Inc.
  • Nestle S.A.
目次
Product Code: A200746

The global enteral syringe market was valued at $383.6 million in 2023, and is projected to reach $643.6 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.

An enteral syringe is a specialized medical device used for administering liquid medications, nutrients, or fluids directly into the gastrointestinal tract, typically through a feeding tube. This syringe is specifically designed with features such as accurate volume measurement, compatibility with enteral feeding tubes, and safety mechanisms to prevent accidental disconnection or leakage.

The growth of the enteral syringe market is driven by poverty, inadequate access to nutritious food, chronic illnesses, and aging populations contribute to the rising incidence of malnutrition cases. Enteral syringes play a crucial role in delivering essential nutrients directly into the gastrointestinal tract, ensuring patients receive adequate nutrition when oral intake is insufficient or not feasible. Moreover, rise in the trend toward home healthcare is driving the market forward. With the rise in the number of patients seeking enteral medication and nutrition at home rather than admitted to hospitals, the demand for user-friendly enteral syringes is growing. Thus, manufacturers are producing syringes that are easy to use and set compatible with home enteral feeding equipment.

However, stringent governmental regulations pose a restraint to the growth of the market growth. Regulatory authorities impose strict standards and approval processes for medical devices, including enteral syringes, to ensure safety, efficacy, and quality. Contrarily, the development of advanced feeding devices with lesser side effects presents an opportunity for the growth of the market. Innovations in enteral syringe design, materials, and functionalities aim to enhance patient comfort, reduce complications, and improve treatment outcomes. For instance, the development of enteral syringes, by Baxter International Inc., with ergonomic designs, precise dosage control mechanisms, and anti-reflux features can minimize the risk of aspiration and tube-related complications, making enteral feeding safer and more efficient.

Segmentation Overview

The enteral syringe market is segmented into type, age group, end user, and region. Depending on the type, the market is bifurcated into reusable and disposable. According to age group, it is divided into adults and pediatrics. According to end user, the market is classified into hospitals, ambulatory surgical centers (ASCS), and home care. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competitive Scenario

The major players operating in the enteral syringe market include Fresenius SE & Co. KGaA, Boston Scientific Corporation, Danone, Cook Medical, Inc., Cardinal Health Inc., Becton, Dickinson and Company, Moog Inc., B. Braun Melsungen AG, Owens & Minor, Inc., and Nestle S.A. Other players in the enteral syringe market include Medtronic PLC, Medline Industries LP, Kentec Medical Inc., Thermo Fisher Scientific Inc, and Baxter International Inc. These players have employed several strategies such as mergers & acquisitions, partnerships, collaboration, and continuous product development and innovation to strengthen their position in the competitive environment.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Reusable
  • Disposable

By Age Group

  • Adults
  • Pediatrics

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Fresenius SE & Co. KGaA
    • Boston Scientific Corporation
    • Danone
    • Cook Medical, Inc.
    • Cardinal Health Inc.
    • Becton, Dickinson and Company
    • Moog Inc.
    • B. Braun Melsungen AG
    • Owens & Minor, Inc.
    • Nestle S.A.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: ENTERAL SYRINGE MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Reusable
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Disposable
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ENTERAL SYRINGE MARKET, BY AGE GROUP

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Age Group
  • 5.2. Adults
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Pediatrics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: ENTERAL SYRINGE MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Homecare
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ENTERAL SYRINGE MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Age Group
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Enteral Syringe Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Age Group
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Enteral Syringe Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Age Group
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Enteral Syringe Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Age Group
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Age Group
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Enteral Syringe Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Age Group
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Enteral Syringe Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Age Group
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Enteral Syringe Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Age Group
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Enteral Syringe Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Age Group
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Enteral Syringe Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Age Group
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Enteral Syringe Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Age Group
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Age Group
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Enteral Syringe Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Age Group
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Enteral Syringe Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Age Group
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Enteral Syringe Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Age Group
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Enteral Syringe Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Age Group
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Enteral Syringe Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Age Group
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Enteral Syringe Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Age Group
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Age Group
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Enteral Syringe Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Age Group
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Enteral Syringe Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Age Group
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Enteral Syringe Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Age Group
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Enteral Syringe Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Age Group
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Fresenius SE And Co. KGaA
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Boston Scientific Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Danone
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Cook Medical, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Cardinal Health Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Becton, Dickinson And Company
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Moog Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. B. Braun Melsungen AG
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Owens And Minor, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Nestle S.A.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments